Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6Neoplasms 5Pain 4Vomiting 3Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 3Nausea 3Colorectal Neoplasms 3Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Osteosarcoma 2Head and Neck Neoplasms 2Depression 2Carcinoma, Non-Small-Cell Lung 2Cancer Pain 2Anxiety Disorders 2Acupuncture 2Xerostomia 1Urinary Incontinence, Stress 1Urinary Incontinence 1Testicular Neoplasms 1Teratoma 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Radiation Injuries 1Prostatic Hyperplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Nausea and Vomiting 1

Interventions

Cognitive Training 2Vitamin D 1Tobacco Use Cessation Devices 1Synbiotics 1Sodium Chloride 1Saline Solution 1Prebiotics 1Palliative Care 1Neuroprotective Agents 1Mesna 1Magnetic Resonance Spectroscopy 1High-Intensity Interval Training 1Functional Status 1Electroacupuncture 1Doxorubicin 1Cyclophosphamide 1Ashwagandha 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Chemotherapy-Related Cognitive Impairment × Electroacupuncture × Clear all
NCT05941598 2023-07-14

Electroacupuncture for Chemotherapy-Related Cognitive Impairment

Beijing University of Chinese Medicine

Phase 2 Unknown
100 enrolled

Chemotherapy-Related Cognitive Impairment

Data powered by HemOnc (CC BY 4.0) Colophon âš¡